In the tumor, we observed an increase in CD45+ tumor-infiltrating cells in the PBS/P2Et group in both models (Figure 3D), which appeared to be CD3+, CD4+, or CD8+ T cells (Figure 3E) and were also more activated (Figure 3F), compared with the control group. This evidence concerns the gene PTPRC and neoplasm.